These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 7243793)
1. Serum levels of PTH, Mg, Ca, inorganic phosphate and alkaline phosphatases in uraemic patients on differentiated Mg dialysis. Gonella M; Moriconi L; Betti G; Bonaguidi F; Buzzigoli G; Bartolini V; Mariani G Proc Eur Dial Transplant Assoc; 1980; 17():362-6. PubMed ID: 7243793 [TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
3. Comparison between different dialysate calcium concentrations in nocturnal hemodialysis. Toussaint ND; Polkinghorne KR; Kerr PG; Somerville CA; Agar JW Hemodial Int; 2007 Apr; 11(2):217-24. PubMed ID: 17403174 [TBL] [Abstract][Full Text] [Related]
4. Long-term effect of different dialysate calcium concentrations on parathyroid hormone levels in hemodialysis patients. Hwang JC; Chen CA; Wang CT; Chen HC Ren Fail; 2008; 30(10):943-51. PubMed ID: 19016144 [TBL] [Abstract][Full Text] [Related]
5. Influence of sevelamer hydrochloride on serum concentration of whole (1-84) and N-terminally truncated (7-84) parathyroid hormone fragments in hemodialysis uremic patients. Chudek J; Piecha G; Kokot F; Wiecek A J Nephrol; 2003; 16(5):710-5. PubMed ID: 14733418 [TBL] [Abstract][Full Text] [Related]
6. Improvement of bone and mineral parameters related to adynamic bone disease by diminishing dialysate calcium. Spasovski G; Gelev S; Masin-Spasovska J; Selim G; Sikole A; Vanholder R Bone; 2007 Oct; 41(4):698-703. PubMed ID: 17643363 [TBL] [Abstract][Full Text] [Related]
7. Association between phosphate removal and markers of bone turnover in haemodialysis patients. Albalate M; de la Piedra C; Fernández C; Lefort M; Santana H; Hernando P; Hernández J; Caramelo C Nephrol Dial Transplant; 2006 Jun; 21(6):1626-32. PubMed ID: 16490746 [TBL] [Abstract][Full Text] [Related]
8. Impact of lowering dialysate calcium concentration on serum bone turnover markers in hemodialysis patients. Hamano T; Oseto S; Fujii N; Ito T; Katayama M; Horio M; Imai E; Hori M Bone; 2005 May; 36(5):909-16. PubMed ID: 15794928 [TBL] [Abstract][Full Text] [Related]
9. Serum ionized calcium, parathyroid hormone and phosphate in uremic patients during and between hemodialysis. Rudnicki M; Frølich A; Haaber A; Tvedegaard E; Thode J Clin Nephrol; 1993 Oct; 40(4):225-9. PubMed ID: 8261680 [TBL] [Abstract][Full Text] [Related]
10. Low Ca2+ dialysate. Effects on bone metabolism in the course of paired filtration dialysis. Carozzi S; Nasini MG; Pietrucci A; Costa M; Mantero R ASAIO J; 1994; 40(3):M683-5. PubMed ID: 8555601 [TBL] [Abstract][Full Text] [Related]
11. On the effect of magnesium on the PTH secretion in uremic patients on maintenance hemodialysis. Gonella M; Bonaguidi F; Buzzigoli G; v Bartolini ; Mariani G Nephron; 1981; 27(1):40-2. PubMed ID: 7219636 [TBL] [Abstract][Full Text] [Related]
12. The requirement of low calcium dialysate in patients on continuous ambulatory peritoneal dialysis receiving calcium carbonate as a phosphate binder. Cheng IK; Lu HB; Chan CY; Cheng SW; Robinson JD; Tam SC; Lo WK; Cheung WC Clin Nephrol; 1993 Aug; 40(2):100-5. PubMed ID: 8222365 [TBL] [Abstract][Full Text] [Related]
13. Effect of the mode of calcitriol administration on PTH-ionized calcium relationship in uraemic patients with secondary hyperparathyroidism. Caravaca F; Cubero JJ; Jimenez F; López JM; Aparicio A; Cid MC; Pizarro JL; Liso J; Santos I Nephrol Dial Transplant; 1995; 10(5):665-70. PubMed ID: 7566580 [TBL] [Abstract][Full Text] [Related]
14. Serum osteoprotegerin level is lower in peritoneal dialysis patients than in hemodialysis ones. Grzegorzewska AE; Młot M Rocz Akad Med Bialymst; 2004; 49():193-6. PubMed ID: 15631342 [TBL] [Abstract][Full Text] [Related]
15. [Hemodialysis with 2.5 mEq/L of calcium in relative hypoparathyroidism: long-term effects on bone mass]. Sánchez Perales MC; García Cortés MJ; Borrego FJ; Fernández Martínez S; Borrego J; Pérez del Barrio P; Liébana A; Pérez Bañasco V Nefrologia; 2000; 20(3):254-61. PubMed ID: 10917002 [TBL] [Abstract][Full Text] [Related]
16. Biological impact of targeted dialysate calcium changes in haemodialysis patients: the key role of parathyroid hormone. Jean G; Mayor B; Hurot JM; Deleaval P; Lorriaux C; Zaoui E; Chazot C Nephrol Dial Transplant; 2013 Jan; 28(1):176-82. PubMed ID: 22764192 [TBL] [Abstract][Full Text] [Related]
17. Calcium-PTH relationship in dialysis patients: the pitfalls of using a constant dialysate calcium concentration during the dynamic tests. De Cristofaro V; Samà F; Pagliari B; Colturi C; Sidoti A; Masa A; Filippini M; Comelli M; Pedrini L Clin Nephrol; 1998 Feb; 49(2):113-20. PubMed ID: 9524782 [TBL] [Abstract][Full Text] [Related]
18. [Replacement of aluminum-containing phosphate binders by calcium and magnesium carbonates in long-term hemodialysis]. Zellweger U; Zaugg PY; Dambacher M; Binswanger U; Gautschi K; Hany A Dtsch Med Wochenschr; 1989 Apr; 114(17):659-64. PubMed ID: 2707134 [TBL] [Abstract][Full Text] [Related]
19. Are PTH serum levels predictive of coronary calcifications in haemodialysis patients? Coen G; Manni M; Mantella D; Pierantozzi A; Balducci A; Condò S; DiGiulio S; Yancovic L; Lippi B; Manca S; Morosetti M; Pellegrino L; Simonetti G; Gallucci MT; Splendiani G Nephrol Dial Transplant; 2007 Nov; 22(11):3262-7. PubMed ID: 17597083 [TBL] [Abstract][Full Text] [Related]
20. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates. Elsharkawy MM; Youssef AM; Zayoon MY Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]